Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1

Br J Haematol. 2006 Feb;132(3):293-302. doi: 10.1111/j.1365-2141.2005.05877.x.

Abstract

CCL20 is expected to play a crucial role in the initiation of immune responses and tumour growth. However, expression of CCL20 in Epstein-Barr virus (EBV)-associated diseases has not been studied. We examined the contribution of EBV infection and EBV-encoded latent membrane protein (LMP)-1 to CCL20 expression. EBV infection and LMP-1 induced CCL20 mRNA expression in the EBV-negative Burkitt lymphoma (BL) cell lines and the embryonic kidney cell line. Histone deacetylase inhibitor-stimulated endogenous LMP-1 also induced CCL20 expression in an EBV-positive BL cell line. Analysis of the CCL20 promoter showed that it was activated by LMP-1 C-terminal activation region (CTAR)-1 and CTAR-2. Co-expression of IkappaB alpha, IkappaB beta, IkappaB kinase (IKK)alpha, IKKbeta, IKKgamma, nuclear factor (NF)-kappaB-inducing kinase and tumour necrosis factor receptor-associated factor 2 dominant-negative constructs with LMP-1 inhibited the activation of the CCL20 promoter by LMP-1, suggesting that LMP-1 induces CCL20 via NF-kappaB signalling. The requirement for the NF-kappaB-binding site in the CCL20 promoter in LMP-1 responsiveness was established. Our results indicate that activation of the NF-kappaB pathway by LMP-1 is required for the activation of CCL20 expression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Burkitt Lymphoma / genetics
  • Burkitt Lymphoma / immunology
  • Cell Line
  • Chemokine CCL20
  • Chemokines, CC / analysis*
  • Epstein-Barr Virus Infections / genetics*
  • Epstein-Barr Virus Infections / immunology
  • Gene Expression Regulation / genetics
  • Gene Expression Regulation / immunology
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / immunology
  • Histone Deacetylase 1
  • Histone Deacetylases / immunology
  • Humans
  • Kidney / immunology
  • Macrophage Inflammatory Proteins / analysis*
  • NF-kappa B / genetics
  • NF-kappa B / immunology
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / immunology
  • Promoter Regions, Genetic / genetics
  • Promoter Regions, Genetic / immunology
  • RNA, Messenger / analysis
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Transcriptional Activation / genetics
  • Transcriptional Activation / immunology
  • Up-Regulation / genetics
  • Up-Regulation / immunology
  • Viral Matrix Proteins / genetics*
  • Viral Matrix Proteins / immunology

Substances

  • CCL20 protein, human
  • Chemokine CCL20
  • Chemokines, CC
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Macrophage Inflammatory Proteins
  • NF-kappa B
  • Neoplasm Proteins
  • RNA, Messenger
  • Viral Matrix Proteins
  • HDAC1 protein, human
  • Histone Deacetylase 1
  • Histone Deacetylases